These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Sickle cell disease clinical phenotypes in children from South-Western, Nigeria. Adegoke SA; Adeodu OO; Adekile AD Niger J Clin Pract; 2015; 18(1):95-101. PubMed ID: 25511352 [TBL] [Abstract][Full Text] [Related]
43. Relevance of fibrinolytic protein (D-dimer) and fibrinopeptide A as markers of sickle cell anaemia vaso-occlusive crisis. Ekwere TA; Ebele U; Ekanem M; Ogunro PS Niger Postgrad Med J; 2014 Sep; 21(3):225-30. PubMed ID: 25331238 [TBL] [Abstract][Full Text] [Related]
44. Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease. Okpala IE; Eze OE; Ezekekwu CA; Nnakenyi ID; Ilechukwu GU; Akpa CO; Nwani EI; Maduka CJ; Anigbogu IO; Muoghalu ED; Ugwu NI; Ajuba IC; Aneke JC; Okoye HC; Nonyelu CC; Duru AN Ghana Med J; 2023 Sep; 57(3):198-203. PubMed ID: 38957672 [TBL] [Abstract][Full Text] [Related]
45. Changes in Blood Profile from Steady State in Patients with Sickle Cell Anemia Admitted for Vaso-occlusive Crisis and Acute Chest Syndrome. Klouda T; Raybagkar D; Bernstein B; Apollonsky N Adv Hematol; 2020; 2020():3656717. PubMed ID: 32908517 [TBL] [Abstract][Full Text] [Related]
46. Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease. Abdulwahab H; Aljishi M; Sultan A; Al-Kafaji G; Sridharan K; Bakhiet M; Taha S Sci Rep; 2021 Nov; 11(1):22199. PubMed ID: 34772994 [TBL] [Abstract][Full Text] [Related]
47. Plasma histamine elevation in a large cohort of sickle cell disease patients. Allali S; Lionnet F; Mattioni S; Callebert J; Stankovic Stojanovic K; Bachmeyer C; Arlet JB; Brousse V; de Montalembert M; Chalumeau M; Grateau G; Maciel TT; Launay JM; Hermine O; Georgin-Lavialle S Br J Haematol; 2019 Jul; 186(1):125-129. PubMed ID: 30924132 [TBL] [Abstract][Full Text] [Related]
49. Lipid and hemolysis parameters predicting acute chest syndrome in adulthood with sickle cell disease. Feugray G; Grall M; Dumesnil C; Brunel V; Benhamou Y; Quillard Muraine M; Billoir P Lipids Health Dis; 2024 May; 23(1):140. PubMed ID: 38755670 [TBL] [Abstract][Full Text] [Related]
50. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition. Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375 [TBL] [Abstract][Full Text] [Related]
51. Comparative study of hypercoagulability change in steady state and during vaso-occlusive crisis among Sudanese patients living with sickle cell disease. Mohamed EA; Elgari MM; Babker AM; Waggiallah HA Afr Health Sci; 2020 Mar; 20(1):392-396. PubMed ID: 33402927 [TBL] [Abstract][Full Text] [Related]
52. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study. Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639 [TBL] [Abstract][Full Text] [Related]
53. Sickle cell acute chest syndrome: pathogenesis and rationale for treatment. Stuart MJ; Setty BN Blood; 1999 Sep; 94(5):1555-60. PubMed ID: 10477680 [TBL] [Abstract][Full Text] [Related]